Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study

Limited information is available on the efficacy of front‐line bendamustine and rituximab (BR) in chronic lymphocytic leukemia (CLL) with reduced renal function or coexisting conditions. We therefore analyzed a cohort of real‐world patients and performed a matched adjusted indirect comparison with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuneo, Antonio, Mato, Anthony R., Rigolin, Gian Matteo, Piciocchi, Alfonso, Gentile, Massimo, Laurenti, Luca, Allan, John N., Pagel, John M., Brander, Danielle M., Hill, Brian T., Winter, Allison, Lamanna, Nicole, Tam, Constantine S., Jacobs, Ryan, Lansigan, Frederick, Barr, Paul M., Shadman, Mazyar, Skarbnik, Alan P., Pu, Jeffrey J., Sehgal, Alison R., Schuster, Stephen J., Shah, Nirav N., Ujjani, Chaitra S., Roeker, Lindsey, Orlandi, Ester Maria, Billio, Atto, Trentin, Livio, Spacek, Martin, Marchetti, Monia, Tedeschi, Alessandra, Ilariucci, Fiorella, Gaidano, Gianluca, Doubek, Michael, Farina, Lucia, Molica, Stefano, Di Raimondo, Francesco, Coscia, Marta, Mauro, Francesca Romana, de la Serna, Javier, Medina Perez, Angeles, Ferrarini, Isacco, Cimino, Giuseppe, Cavallari, Maurizio, Cucci, Rosalba, Vignetti, Marco, Foà, Robin, Ghia, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666748/
https://www.ncbi.nlm.nih.gov/pubmed/32969597
http://dx.doi.org/10.1002/cam4.3470

Ejemplares similares

Ejemplares similares